Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 7, 2010
Financial News
Cynapsus amends private placement of units
...Type: Private placement of units To be raised: Up to C$2.5 million (US$2.4 million) Underwriter:
Wellington West
...
Read More
BioCentury
|
May 25, 2005
Financial News
Liponex files for IPO
...on a best efforts basis through Jennings Capital; Canaccord Capital; Haywood Securities; Dundee Securities; and
Wellington West
...
Read More
BioCentury
|
Jan 3, 2005
Finance
Ebb & Flow
...cell lung cancer (NSCLC). The deal was underwritten by Canaccord; Jennings Capital; McFarlane Gordon; and
Wellington West
...
Read More
BioCentury
|
Dec 30, 2004
Financial News
Chemokine prices IPO
...post-money valuation of C$29.3 million ($23.8 million). Underwriters were Canaccord; Jennings Capital; McFarlane Gordon; and
Wellington West
...
Read More
BioCentury
|
Dec 1, 2000
Financial News
Medicure to raise up to C$20 million
...to C$20 million (US$13 million) in a unit offering in Canada through Groome Capital.com and
Wellington West
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Jun 7, 2010
Financial News
Cynapsus amends private placement of units
...Type: Private placement of units To be raised: Up to C$2.5 million (US$2.4 million) Underwriter:
Wellington West
...
Read More
BioCentury
|
May 25, 2005
Financial News
Liponex files for IPO
...on a best efforts basis through Jennings Capital; Canaccord Capital; Haywood Securities; Dundee Securities; and
Wellington West
...
Read More
BioCentury
|
Jan 3, 2005
Finance
Ebb & Flow
...cell lung cancer (NSCLC). The deal was underwritten by Canaccord; Jennings Capital; McFarlane Gordon; and
Wellington West
...
Read More
BioCentury
|
Dec 30, 2004
Financial News
Chemokine prices IPO
...post-money valuation of C$29.3 million ($23.8 million). Underwriters were Canaccord; Jennings Capital; McFarlane Gordon; and
Wellington West
...
Read More
BioCentury
|
Dec 1, 2000
Financial News
Medicure to raise up to C$20 million
...to C$20 million (US$13 million) in a unit offering in Canada through Groome Capital.com and
Wellington West
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page